Trial | NCT03458468  Report issue

Title

Tranexamic Acid for the Latarjet Procedure.
A Randomised, Prospective Evaluation on the Effectiveness of Tranexamic Acid in Reducing Postoperative Swelling and Haematoma Formation After the Latarjet Procedure.

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    100
The investigators propose a double-blinded randomized study evaluating the effectiveness of tranexamic acid in reducing postoperative swelling and haematoma formation after the Latarjet procedure.

The purpose of this study is to assess the efficacy of tranexamic acid (TXA), given via intra-articular injection at the time of surgery in patients undergoing the Latarjet procedure for shoulder instability.
Study Started
Mar 01
2018
Primary Completion
Mar 01
2019
Study Completion
Mar 01
2019
Last Update
Jul 30
2019

Drug Tranexamic Acid

1g Tranexamic acid prior to skin incision

Drug Saline

Equivalent volume of saline prior to skin incision

Group A Experimental

Tranexamic Acid 1g IV

Group B Placebo Comparator

Saline injection

Criteria 

Inclusion Criteria:

• Anterior shoulder instability, warranting the Latarjet procedure

Exclusion Criteria:

Patients with known risk factors for hyper-coagulable state
Patients under 16
Patients unable to give consent to partake in the trial
No Results Posted